近期论文
查看导师最新文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
Huang P, Zhuang B, Zhang H, Yan H, Xiao Z, Li W, Zhang J, Tang Q, Hu K, Koeffler HP, Wang J*.Dong Yin*. Clin Cancer Res, Hepatitis B virus X protein (HBx) is responsible for resistance to targeted therapies in hepatocellular carcinoma: ex vivo culture evidence. 2015 Oct 1;21(19):4420-30. (Co-Correspondence Author) De-Chen Lin*, Liang Xu, Ye Chen, Haiyan Yan, Masaharu Hazawa, Ngan Doan, Jonathan W. Said, Ling-Wen Ding, Li-Zhen Liu, Henry Yang, Shizhu Yu, Michael Kahn, Dong Yin*, H. Phillip Koeffler. Genomic and functional analysis of the E3 ligase PARK2 in glioma. Cancer Research. 2015, 75(9):1815-27. (Co-Correspondence Author) Heyun Zhang, Wenbin Li, P. Huang, L. Lin, H. Ye, Z. Xiao, D. Lin, HP. Koeffler，Jie Wang*, Dong Yin*. Expression of CCN Family Members Correlates with Clinical Features in Hepatocellular Carcinoma. 2015, Oncology Reports 33: 1481-1492. (Co-Correspondence Author) Jin S, Wang K, Xu K, Xu J, Sun J, Chu Z, Lin D, Koeffler PH, Wang J, Yin Dong. Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma.Oncotarget. 2014 Jun 15;5(11):3685-96.(Co-Correspondence Author) Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, Garg M, Liu LZ, Yang H, Yin Dong, Shi ZZ, Jiang YY, Gu WY, Gong T, Zhang Y, Xu X, Kalid O, Shacham S, Ogawa S, Wang MR, Koeffler HP.Genomic and molecular characterization of esophageal squamous cell carcinoma.Nat Genet. 2014 Mar 30. 46(5), pp 467-473 Xu L, Lin DC, Yin Dong, Koeffler HP. An emerging role of PARK2 in cancer. J MolMed (Berl). 2014 Jan;92(1):31-42. Epub 2013 Dec3 (Co-Correspondence Author) Lin DC, Xu L, Ding LW, Sharma A, Liu LZ, Yang H, Tan P, Vadgama J, Karlan BY, Lester J, Urban N, Schummer M, Doan N, Said JW, Sun H, Walsh M, Thomas CJ, Patel P, Dong Yin, Chan D, Koeffler HP. Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancers. ProcNatlAcadSci U S A. 2013 Apr 9;110(15):6109-14. Lin L, Gaut D, Hu K, Yan H, Yin Dong, Koeffler HP. Dual targeting of glioblastomamultiforme with a proteasome inhibitor (Velcade) and a phosphatidylinositol3-kinase inhibitor (ZSTK474). Int J Oncol. 2014 Feb;44(2):557-62. Epub 2013 Dec 2.(Correspondence Author) Tang W, Yu F, Yao H, Cui X, Jiao Y, Lin L, Chen J, Yin Dong, Song E, Liu Q.miR-27a regulates endothelial differentiation of breast cancer stem like cells.Oncogene. 2014；33(20):2629-38 Hayano T, Garg M, Dong Yin, Sudo M, Kawamata N, Shi S, Chien W, Ding LW, Leong G, Mori S, Xie D, Tan P, Koeffler HP. SOX7 is down-regulated in lung cancer. J ExpClin Cancer Res. 2013 Apr 4;32(1):17. [Epub ahead of print] Dong Yin, Yang WG, Weissberg J, Goff CB, Chen W, Kuwayama Y, Leiter A, Xing H, Meixel A, Gaut D, Kirkbir F, Sawcer D, Vernier PT, Said JW, Gundersen MA, Koeffler HP (2012),Cutaneous Papilloma and Squamous Cell Carcinoma Therapy Utilizing Nanosecond Pulsed Electric Fields (nsPEF). PLOS ONE 2012;7(8):e43891 (Correspondence Author) Dong Yin, Seishi Ogawa, Norihiko Kawamata, Amanda Leiter, Michelle Ham, Dong Li, Ngan B Doan, Jonathan W. Said, Keith L. Black, H. Phillip Koeffler (2013). miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme. Oncogene, 2013 Feb 28;32(9):1155-63. (Correspondence Author) Yin Z, Liu C, Chen Y, Bai Y, Shang C, Yin R, Dong Yin, Wang J. Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or Delayed? Hepatology 2013 Jun;57(6):2346-57 (Co-Correspondence Author) Yin Z, Fan X, Ye H, Dong Yin, Wang J. Short- and Long-term Outcomes after Laparoscopic and Open Hepatectomy for Hepatocellular Carcinoma: A Global Systematic Review and Meta-analysis. Ann SurgOncol. 2012 Oct 26.20(4):1203-15 Yin Z, Dong Yin, Wang J. A meta-analysis for percutaneous tumour ablation in patients with small hepatocellular carcinoma: highlighting combined strategy in the future. Gut. 2013;62(3):477-478 Yang YL, Fan Y, Lang RG, Gu F, Ren MJ, Zhang XM, Yin Dong, Fu L. Genetic heterogeneity of HER2 in breast cancer: impact on HER2 testing and its clinicopathologic significance. Breast Cancer Res Treat. 2012 Aug;134(3):1095-102. Epub 2012 Apr 5. Liu F, Lang R, Zhao J, Zhang X, Pringle GA, Fan Y, Yin Dong, Gu F, Yao Z, Fu L. CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat. 2011 Nov;130(2):645-55. Epub 2011 Jun 30. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Dong Yin, Karlan B, Vadgama J, Lyons KM, Koeffler HP (2011). Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol. 2011;38(6):1741-1747 Weikai Chen, Amada Leiter, Dong Yin, Meiring M, Louw VJ, Koeffler HP (2010). Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines. International Journal of Oncology. 37(3):737-743. (Correspondence Author) Dong Yin, James O'Kelly, Daning Lu, Michelle Ham, Weikai Chen, Dong Xie, Ngan B Doan, Charles Wang, Jay Vadgama, Jonathan Said，Keith Black and H. Phillip Koeffler (2010). CTGF induces cell growth in vitro and in vivo, migration, as well as, drug resistance in glioblastoma multiforme. International Journal of Cancer. 127(10):2257-67 (Correspondence Author) Qi Cao, SigalGery, AzadehDashti, Dong Yin, Yan Zhou, Jiang Gu, H. Phillip Koeffler (2009). A Role for the Clock Gene Per1 in Prostate Cancer. Cancer Res. 69(19):7619-25 Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, Song JH, Dong Yin, Toh M, Xie WD, Said JW, Koeffler HP. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res. 2009 Jul 15;69(14):5876-84 Dong Yin, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C，Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black K, Koeffle HP (2009). High resolution genomic copy number profiling of GBM by single nucleotide polymorphism DNA microarray. Molecular Cancer Research. 7(5):665-77. (Correspondence Author)
京公网安备 11010802027423号